News | Magnetic Resonance Imaging (MRI) | November 13, 2017

Aspect Imaging Receives CE Mark for Embrace Neonatal MRI System

System allows preparation and scanning of newborns without transporting them from the NICU

November 13, 2017 — Aspect Imaging announced last week that it received CE marking for the neonatal-dedicated Embrace Neonatal Magnetic Resonance Imaging (MRI) System, which enables preparation and scanning of newborns without having to transport them from the NICU. Embrace Neonatal MRI can now be used and sold in EU countries and in non-EU countries that rely on CE certification.

Aspect Imaging developed Embrace Neonatal MRI System to be placed inside the NICU to reduce the time and risks involved with transporting infants to an external facility in which traditional MRI scanners are typically situated. The system enables safer imaging of infants (weighing from 1 Kg to 4.5 Kg) and provides easier access for medical staff during the scanning process. The system can prep and scan in less than an hour. Intubated infants can also be scanned without disconnecting and reconnecting the tubing from the infant, due to the unique design of Embrace. The system is acoustically quieter during scanning compared to traditional whole-body scanners, and has a permanent magnet that is always active and thus requires no electrical, cryogenic or water cooling.

Embrace Neonatal MRI System does not require a special safety zone or an RF-shielded room, therefore, the system can be placed inside the NICU. Since the system is fully enclosed, medical device implants in close proximity (outside the magnet bore), are not required to be ‘MR Conditional’ or ‘MR Safe.’

The operating and maintenance costs of the system are much lower than conventional superconductor MRIs, according to Aspect, due to the company’s magnet technology, which requires no cooling system and has low power consumption.

Additionally, the Embrace Neonatal MRI system has an integrated, temperature-controlled incubator-like patient bed which minimizes movement of the baby.

For more information: www.aspectimaging.com

Related Content

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...